glp 1 for cardiovascular disease Could GLP-1 medications be helpful your heart? Our experts weigh in on the potential benefits and side effects of the popular weight loss medications GLP-1 Agonists in Cardiovascular Diseases:

Beyond GLP-1: efficacy and safety of dual and triple incretin agonists in personalized type 2 diabetes care-a systematic review and network meta-analysis

Laboratory schedule: Baseline (before taper starts): serum potassium, creatinine, blood pressure 1 to 2 weeks after final dose: repeat potassium if baseline was borderline (4.5 to 5.0 mEq/L) or if the patient takes ACE inhibitors or ARBs 3 months post-discontinuation: clinical acne assessment Blood pressure typically normalizes within days of stopping

While the studies by Lebrun et al have exciting implications for the treatment of gut injury and critical illness, the precise cell types (i.e

Saxagliptin vs

If youre needle-averse now but want to try the pill later, or want to switch between formats, choose a programme that offers flexibility

By balancing the potential benefits and risks of treatment using evidence-based strategies, HCPs are well placed to help optimise the use of GLP-1 RAs in the management of obesity and overweight